Once cautious, OpenAI, Grok, and others will now dive into giving unverified medical advice with virtually no disclaimers.

As Microsoft, Intel, and Google lean into AI-driven restructuring, workers face shrinking salaries, fewer entry-level roles, ...

The Food and Drug Administration has granted permission for Juul to continue selling its e-cigarettes, offering some reprieve ...

Isomorphic Labs, a Google-backed AI company, is set to begin human trials for cancer drugs designed by AI, raising both hope ...

For Stephen Yeager, who owns a Theodore company that helps lawyers with digital forensics, research and jury consulting, artificial intelligence has been a “game-changer.” But there are potential ...

The UK now has one of the most energy-efficient supercomputers in the world, with the unveiling of the new Isambard-AI ...

Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

In an industry where 90 percent of drug candidates fail before reaching the market, a handful of startups are betting ...

OpenEvidence, dubbed the 'ChatGPT for doctors,' uses AI to simplify evidence-based medical information for physicians, now ...

Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...

However, ChatGPT, Copilot, Deepseek and Meta AI failed to mention that if you enroll in a Medicare Advantage plan and later want to switch to original Medicare, you can be rejected for a Medigap plan ...

Artificial intelligence startup OpenEvidence banked a $210 million series B round as it looks to expand its strategic content ...